2022 World Cancer Diagnostics Market: Supplier Shares in US, Europe, and Japan-Competitive Analysis of Leading and Emerging Market Players
This new report provides cancer diagnostics market shares for the following countries:
France, Germany, Italy, Japan, Spain, UK, and US.
The report analyzes current and emerging suppliers of cancer diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
France, Germany, Italy, Japan, Spain, UK, and US.
The report analyzes current and emerging suppliers of cancer diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
COMPANY ASSESSMENTS
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
Abbott
Affymetrix
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujifilm Wako
Fujirebio
Grifols
Hologic/Gen-Probe
Leica Biosystems/Kreatech
Ortho-Clinical Diagnostics/Carlyle Group
Qiagen
Roche
Siemens Healthineers
Takara Bio
Thermo Fisher and others.
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
Abbott
Affymetrix
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujifilm Wako
Fujirebio
Grifols
Hologic/Gen-Probe
Leica Biosystems/Kreatech
Ortho-Clinical Diagnostics/Carlyle Group
Qiagen
Roche
Siemens Healthineers
Takara Bio
Thermo Fisher and others.
